2,019
Views
8
CrossRef citations to date
0
Altmetric
Cardiovascular

Antidiabetic agents and cardiovascular outcomes in patients with heart diseases

, , &
Pages 985-992 | Received 15 Nov 2016, Accepted 16 Jan 2017, Published online: 15 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. Rick Turner. (2017) Integrated cardiovascular safety: multifaceted considerations in drug development and therapeutic use. Expert Opinion on Drug Safety 16:4, pages 481-492.
Read now

Articles from other publishers (7)

Jiarui Yuan. (2023) Effect of Glipizide on non-insulin-dependent diabetes mellitus. Highlights in Science, Engineering and Technology 54, pages 219-224.
Crossref
Juliana Nogueira Garcia & Jardel Côrrea de Oliveira. (2022) Revisão sobre o uso de inibidores de cotransportador sódio-glicose 2 e agonistas de peptídeo 1 em pessoas com diabetes mellitus tipo 2 e doença cardiovascular. Revista Brasileira de Medicina de Família e Comunidade 17:44, pages 2428.
Crossref
Filip Gnesin, Anne Cathrine Baun Thuesen, Lise Katrine Aronsen Kähler, Sten Madsbad & Bianca Hemmingsen. (2020) Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2020:6.
Crossref
Hongzhong Ma, Juan Du, Xiaoli Feng, Yingjun Zhang, Haihuan Wang, Suchun Ding, Aijie Huang & Jiahai Ma. (2020) Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF‑κB signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Laura K. Triantafylidis, Chelsea E. Hawley, Laura P. Perry & Julie M. Paik. (2018) The Role of Deprescribing in Older Adults with Chronic Kidney Disease. Drugs & Aging 35:11, pages 973-984.
Crossref
Vivian Szeto, Nai-hong Chen, Hong-shuo Sun & Zhong-ping Feng. (2018) The role of KATP channels in cerebral ischemic stroke and diabetes. Acta Pharmacologica Sinica 39:5, pages 683-694.
Crossref
Raffaele Altara, Mauro Giordano, Einar S. Nordén, Alessandro Cataliotti, Mazen Kurdi, Saeed N. Bajestani & George W. Booz. (2017) Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction. Frontiers in Endocrinology 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.